Generics keep global healthcare spending in check by offering affordable alternatives to expensive brand-name drugs. Without them, millions couldn't afford treatment, and healthcare systems would collapse under rising costs.
Annual savings from FDA generic drug approvals have reached hundreds of billions in the U.S., with $445 billion saved in 2023 alone. This breakdown shows how new generic approvals drive cost reductions and who benefits most.
Authorized generics and first-to-file generics both lower drug costs, but authorized generics drive prices down faster and deeper. Learn how competition between them saves patients and the healthcare system money.
Learn the real eligibility rules for patient assistance programs from drug companies - income limits, insurance requirements, and how to avoid common application mistakes that lead to denial.
A practical guide that helps myeloma patients and their families navigate costs, benefits, and budgeting to secure financial stability.